Identification of Selective Mtb-DHFR Inhibitors as Antitubercular Agents: A Fragment Merging Approach
{{output}}
Introduction: Tuberculosis (TB) is the world's deadliest disease, with 8.2 million new cases reported in 2023. There are many druggable targets for tuberculosis, out of which Dihydrofolate reductase from M. tuberculosis (Mtb-DHF... ...
